Breye Therapeutics ApS is a Danish APS based in Hørsholm, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2019, the company has 4 employees and reported a gross profit of -DKK 7.5m in its latest annual filing.
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse
Company purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
In its most recent annual report (2025), Breye Therapeutics ApS reported a gross profit of -DKK 7.5m. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 89.1m.
At the end of 2025, current assets covered short-term debt 0.5 times.
Frequently asked questions
What is the CVR number of Breye Therapeutics ApS?
Breye Therapeutics ApS is registered with CVR / Virk under CVR 40279865.
What is the gross profit of Breye Therapeutics ApS?
Breye Therapeutics ApS reported a gross profit of -DKK 7.5m in 2025.
How many employees does Breye Therapeutics ApS have?
Breye Therapeutics ApS employs 4 people as of the latest annual report.
Who is the CEO of Breye Therapeutics ApS?
Ulrik Mouritzen is the CEO of Breye Therapeutics ApS.
Who is the chairman of Breye Therapeutics ApS?
Jimmy Arnold V Van Heusden chairs the board of Breye Therapeutics ApS, in role since 2022.
Where is Breye Therapeutics ApS headquartered?
Breye Therapeutics ApS's registered address is Agern Alle 24.
